GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.690
+0.090 (1.96%)
At close: Jun 23, 2025, 4:00 PM
4.550
-0.140 (-2.99%)
After-hours: Jun 23, 2025, 7:51 PM EDT
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $1.80 billion as of June 23, 2025. Its market cap has decreased by -41.31% in one year.
Market Cap
1.80B
Enterprise Value
2.04B
1-Year Change
-41.31%
Ranking
Category
Stock Price
$4.69
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $1.80B, a decrease of -85.80%. That is a compound annual growth rate of -33.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 1.76B | -1.38% |
| Dec 31, 2024 | 1.79B | -34.24% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | 15.79B | 24.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |